Preoperative Peripheral Blood Count in Breast Carcinoma: Predictor of Prognosis or a Routine Test

Table 4

Relation of various leucocytic parameters with four stages of carcinoma and benign group.

Leucocytic parameters	Carcinoma stage				Benign group
	1	2	3	4
TLC (mean ± SD)	9.100 ± 2.998	8.619 ± 2.930	7.404 ± 1.686	6.222 ± 1.580	8.543 ± 2.400
Minimum TLC	7.000	16.560	10.970	3.550	4.900
Maximum TLC	11.240	5.200	4.630	7.670	14.200
N (mean ± SD)	3.800 ± 0.325	5.829 ± 2.907	4.614 ± 1.209	4.454 ± 1.098	5.380 ± 1.760
Minimum N	3.600	2.180	7.680	2.730	3.000
Maximum N	4.060	14.170	2.850	5.500	9.200
L (mean ± SD)	5.800 ± 3.676	2.289 ± 1.024	2.127 ± 0.641	1.379 ± 0.762	2.753 ± 0.656
Minimum L	3.200	1.100	0.840	0.500	1.600
Maximum L	8.400	4.200	3.500	2.277	3.800
M (mean ± SD)	0.33 ± 0.25	0.33 ± 0.26	0.30 ± 0.23	0.20 ± 0.05	0.226 ± 0.209
Minimum M	0.150	0.100	0.010	0.138	0.010
Maximum M	0.510	1.106	1.106	0.260	0.650
E (mean ± SD)	0.06 ± 0.04	0.12 ± 0.07	0.21 ± 0.15	0.10 ± 0.03	0.066 ± 0.066
Minimum E	0.030	0.000	0.000	0.040	0.008
Maximum E	0.100	0.250	0.550	0.138	0.200